
By Kapitall : Do you consider a stock's sales trends when comparing names? For ideas on how to start your own sales analysis, we ran a screen. We began by screening the healthcare sector for stocks with high growth prospects, with 5-year projected EPS growth above 15%. We then screened these names
NxStage Medical ( NXTM ): Q1 EPS of -$0.09 in-line. Revenue of $57M (+12.9% Y/Y) in-line. ( PR ) Post your comment!
day, ladies and gentlemen, and welcome to the NxStage Medical 's First Quarter Fiscal 2012 Financial Results ..... Karen, and good morning everyone. Welcome to NxStage Medical 's first quarter 2012 financial results conference
Leerink calls out NxStage Medical ( NXTM +1.6% ) for a quick gain today after the Medicare Payment Advisory Committee released a report last night that included a positive spin on home hemodialysis reimbursement - viewed as positive for the company. Post your comment!
By Stephen Simpson : Outside of pharmaceuticals and "big iron" applications like imaging, Japanese companies haven't made much impression on the U.S. healthcare market. That may be changing, though. As Japan faces its own aging population and companies look to diversify from traditional industries,
NxStage Medical ( NXTM ): Q4 EPS of -$0.08 beats by $0.01 . Revenue of $57M (+14.5% Y/Y) beats by $1M . ( PR ) Post your comment!
day, ladies and gentlemen, and welcome to the NxStage Medical 's Fourth Quarter Fiscal 2011 Financial Results ..... Stephanie, and good morning everyone. Welcome to NxStage Medical 's fourth quarter and full year 2011 financial
NxStage Medical ( NXTM -2.9% ) drops on a downgrade to Hold from Feltl & Co. Feltl considers NxStage shares to be richly priced on an enterprise
By Kapitall : Accounts receivable is a big part of revenue for many companies, including the healthcare sector, but it is also a potential source of problems. Receivables represent money earned but not yet collected, so when receivables become a larger part of the revenue reported by a company, it
We are no longer providing equity research on NxStage Medical NXTM . We provide broad coverage of more than 1,700 companies across more than 140 industries and adjust our coverage as necessary based on client demand and investor interest.